[LGND] QoQ Quarter Result on 31-Mar-2021 [#Q1]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
06-May-2021
Financial Year
2021
Quarter
31-Mar-2021 [#Q1]
Profit Trend
QoQ- 214.29%
YoY- 175.03%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
Revenue 72,473 64,835 84,675 55,150 69,990 41,848 41,420 45.05%
PBT -7,026 15,259 33,301 5,764 3,370 -11,612 28,119 -
Tax -2,058 1,536 2,576 -12,342 -2,391 -4,911 6,033 -
NP -4,968 13,723 30,725 18,106 5,761 -6,701 22,086 -
Tax Rate - -10.07% -7.74% 214.12% 70.95% - -21.46% -
Total Cost 77,441 51,112 53,950 37,044 64,229 48,549 19,334 151.57%
Ratio Analysis
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
NP Margin -6.85 21.17 36.29 32.83 8.23 -16.01 53.32 -
Per Share
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
EPS -0.30 0.82 1.84 1.10 0.36 -0.42 1.38 -
EPS Diluted -0.30 0.80 1.79 1.05 0.35 -0.42 1.32 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.